Clinical Trial Update: Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase I trial of hypofractionated stereotactic boost radiotherapy for non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: West Virginia University | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED